HomeORCHPHARMA • NSE
add
Orchid Pharma Ltd
Previous close
₹723.00
Day range
₹709.30 - ₹733.45
Year range
₹603.80 - ₹1,997.40
Market cap
36.52B INR
Avg Volume
181.14K
P/E ratio
36.64
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.37B | 9.39% |
Operating expense | 803.51M | 65.13% |
Net income | 222.95M | -33.50% |
Net profit margin | 9.39 | -39.18% |
Earnings per share | 4.40 | — |
EBITDA | 277.48M | -6.06% |
Effective tax rate | -0.18% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.80B | 4,868.40% |
Total assets | 16.88B | 8.63% |
Total liabilities | 4.21B | 9.42% |
Total equity | 12.67B | — |
Shares outstanding | 50.67M | — |
Price to book | 2.89 | — |
Return on assets | — | — |
Return on capital | 3.38% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 222.95M | -33.50% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Founded
1992
Website
Employees
871
